FOLH1 and prostate carcinoma: The results of the in vitro cell-binding assay, using 22Rv1 PSMA-positive human prostate cancer cell line, were obtained using a γ scintillation counter (DREAM G-10, Shinjin Medics Inc., Shinjin, Korea), making the use of these compounds promising for prostate cancer imaging.